Compare American International Group Inc (AIG) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American International Group Inc vs TransMedics Group Inc — how do they compare? American International Group Inc trades at $76.02 (market cap $40.42B), while TransMedics Group Inc trades at $87.08 (market cap $3.10B). The key difference: American International Group Inc is far larger — about 13× TransMedics Group Inc's market cap, and American International Group Inc pays a 2.59% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| AIG | TMDX | |
|---|---|---|
Market Cap | $40.42B | $3.10B |
Sector | Financials | Technology |
52-Week High | $86.59 | $150.42 |
52-Week Low | $71.89 | $61.99 |
Enterprise Value | $48.06B | $3.49B |
Dividend Yield | 2.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AIG trades at $76.33, down 1.65% on the day, with a bearish technical signal and neutral oscillators. The company shows strong earnings momentum with three consecutive quarterly beats (Q4 2025: $1.96 vs $1.90 expected, Q1 2026: $2.11 vs $1.89, Q2 2026: $2.00 vs $1.92) and maintains a 11.12% net income margin. Recent news highlights CEO Eric Anderson discussing geopolitical opportunities and strong Q2 results with 10% adjusted EPS growth.
AIG presents a mixed outlook with solid fundamentals and earnings consistency offset by bearish technicals. The 12-month consensus price target of $89.00 suggests 16.6% upside potential, supported by 39% analyst buy ratings. Key risks include competitive pricing pressure in North American property insurance and market volatility. The stock's current valuation at 14.11 P/E appears reasonable given earnings growth trajectory.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American International Group Inc
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.
Read more on AIG →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
